Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-07 Purchase |
2025-02-11 7:00 pm |
Oncocyte Corp | OCX | James Andrea S. Chief Financial Officer |
97,561 | $2.05 | $200,000 | 151,231 (Direct) |
View |
| 2024-12-05 Purchase |
2024-12-09 08:00 am |
Oncocyte Corp | OCX | James Andrea S. Chief Financial Officer |
20,000 | $2.29 | $45,800 | 53,670 (Direct) |
View |
| 2024-10-02 Purchase |
2024-10-04 7:40 pm |
Oncocyte Corp | OCX | James Andrea S. Chief Financial Officer |
33,670 | $2.97 | $100,000 | 33,670 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-26 Option Award |
2025-03-28 4:05 pm |
N/A N/A |
Oncocyte Corp | OCX | James Andrea S. Chief Financial Officer |
113,207 | $0 | 113,207 (Direct) |
View |
| 2024-10-11 Option Award |
2024-10-15 4:15 pm |
N/A 2034-06-20 |
Oncocyte Corp | OCX | James Andrea S. Chief Financial Officer |
300,000 | $0 | 300,000 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-24 4:49 pm |
N/A N/A |
Oncocyte Corp | OCX | James Andrea S. Chief Financial Officer |
300,000 | $0 | 500,000 (Direct) |
View |